Intellectual Property India Publishes Patent Application for 'GCN2 Modulator For Treating Cancer' Filed by Hibercell, Inc.

MUMBAI, India, Oct. 31 -- Intellectual Property India has published a patent application (202417100431 A) filed by Hibercell, Inc., New York, on Dec. 18, 2024, for 'gcn2 modulator for treating cancer.'

Inventor(s) include Bose, Nandita; Gargano, Michele; Iglesias, Jose; Mulvihill, Mark J; Oliver-Shaffer, Patricia; Surguladze, David; Ramurthy, Savithri; and Tameire, Feven.

The application for the patent was published on Oct. 31, under issue no. 44/2025.

According to the abstract released by the Intellectual Property India: "Provided herein are methods of treating advanced solid tumors in a subject in need thereof, for example, when the subject has advanced squamous cell carcinoma of the head and neck, colorectal cancer, non-small cell lun...